J Med Chem. 2009 Aug 13;52(15):4757-73.

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.

Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A.

Source

Dipartimento di Scienze Farmaceutiche, Università di Pisa, via Bonanno 6, 56126 Pisa, Italy.

Abstract

Matrix metalloproteinase-13 (MMP-13) is a key enzyme implicated in the degradation of the extracellular matrix in osteoarthritis (OA). For this reason, MMP-13 synthetic inhibitors are being sought as potential therapeutic agents to prevent cartilage degradation and to halt the progression of OA. Herein, we report the synthesis and in vitro evaluation of a new series of selective MMP-13 inhibitors possessing an arylsulfonamidic scaffold. Among these potential inhibitors, a very promising compound was discovered exhibiting nanomolar activity for MMP-13 and was highly selective for this enzyme compared to MMP-1, -14, and TACE. This compound acted as a slow-binding inhibitor of MMP-13 and was demonstrated to be effective in an in vitro collagen assay and in a model of cartilage degradation. Furthermore, a docking study was conducted for this compound in order to investigate its binding interactions with MMP-13 and the reasons for its selectivity toward MMP-13 versus other MMPs.

PMID:: 19606871; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Chemical Information

BindingDB

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Design strategies for the identification of MMP-13 and Tace inhibitors. [Curr Opin Drug Discov Devel. 2...]
Review Design strategies for the identification of MMP-13 and Tace inhibitors.
Skotnicki JS, DiGrandi MJ, Levin JI. Curr Opin Drug Discov Devel. 2003 Sep; 6(5):742-59.
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis. [J Med Chem. 2003]
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, et al. J Med Chem. 2003 Jun 5; 46(12):2376-96.
Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis. [J Med Chem. 2003]
Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Aranapakam V, Grosu GT, Davis JM, Hu B, Ellingboe J, Baker JL, Skotnicki JS, Zask A, DiJoseph JF, Sung A, et al. J Med Chem. 2003 Jun 5; 46(12):2361-75.
Review The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE. [Curr Top Med Chem. 2004]
Review The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
Levin JI. Curr Top Med Chem. 2004; 4(12):1289-310.
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. [Arthritis Rheum. 2009]
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM, Becher G, Bendele AM, Biesinger R, Bluhm H, Boer J, Deng H, Dodd R, Essers M, Feuerstein T, et al. Arthritis Rheum. 2009 Jul; 60(7):2008-18.

See reviews... See all...

Cited by 3 PubMed Central articles

MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. [Breast Cancer Res. 2011]
MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu-Rumeileh I, Balestreri L, Borsatti E, Tripodo C, Colombatti A, Spessotto P. Breast Cancer Res. 2011 Oct 27; 13(5):R105. Epub 2011 Oct 27.
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. [Mol Cancer. 2010]
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.
Meierjohann S, Hufnagel A, Wende E, Kleinschmidt MA, Wolf K, Friedl P, Gaubatz S, Schartl M. Mol Cancer. 2010 Jul 28; 9:201. Epub 2010 Jul 28.
Review Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected]. [Life Sci. 2010]
Review Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].
Singh R, Akhtar N, Haqqi TM. Life Sci. 2010 Jun 19; 86(25-26):907-18. Epub 2010 May 10.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological e...
N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
J Med Chem. 2009 Aug 13 ;52(15):4757-73.

PubMed
[Microwave ablation of liver tumors as a new instrument for minimally invasive l...
[Microwave ablation of liver tumors as a new instrument for minimally invasive liver surgery].
Pol Merkur Lekarski. 2009 May ;26(155):545-9.

PubMed
Criminalization confusion and concerns: the decade since the Cuerrier decision.
Criminalization confusion and concerns: the decade since the Cuerrier decision.
HIV AIDS Policy Law Rev. 2009 May ;14(1):1, 5-10.

PubMed
Acupuncture stimulation improves balance function in stroke patients: a single-b...
Acupuncture stimulation improves balance function in stroke patients: a single-blinded controlled, randomized study.
Am J Chin Med. 2009 ;37(3):483-94.

PubMed
Social loafing and social compensation: the effects of expectations of co-worker...
Social loafing and social compensation: the effects of expectations of co-worker performance.
J Pers Soc Psychol. 1991 Oct ;61(4):570-81.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Chemical Information

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information